Cargando…
Evaluation of a Generic Bortezomib Molecule in Newly Diagnosed Multiple Myeloma Patients
OBJECTIVE: Constantly increasing health expenditures lead to the use of generic molecules and generic versions of bortezomib have been used for a long time. The aim of this study is to retrospectively examine the effectiveness, side effects, and reliability of generic bortezomib in newly diagnosed m...
Autores principales: | Mersin, Sinan, Gedük, Ayfer, Mehtap, Özgür, Tarkun, Pınar, Ünal, Serkan, Gökçen Polat, Merve, Aygün, Kemal, Yenihayat, Emel Merve, Albayrak, Hayrunnisa, Hacıhanefioğlu, Abdullah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386308/ https://www.ncbi.nlm.nih.gov/pubmed/33947178 http://dx.doi.org/10.4274/tjh.galenos.2021.2020.0555 |
Ejemplares similares
-
The role of hepcidin, GDF15, and mitoferrin-1 in iron metabolism of polycythemia vera and essential thrombocytosis patients
por: ALBAYRAK, Canan, et al.
Publicado: (2019) -
Excellent Interim Treatment Response with Polatuzumab Vedotin
por: Mehtap, Özgür, et al.
Publicado: (2020) -
Spontaneous Remission in Paroxysmal Nocturnal Hemoglobinuria: An Extremely Rare Case
por: Mehtap, Özgür, et al.
Publicado: (2022) -
The Association Between Gene Polymorphisms and Leukocytosis with Thrombotic Complications in Patients with Essential Thrombocythemia and Polycythemia Vera
por: Mehtap, Özgür, et al.
Publicado: (2012) -
Long-Term Efficacy of Erythropoiesis-Stimulating Agents in Patients with Low-Risk or Intermediate-1-Risk Myelodysplastic Syndrome: Multicenter Real-Life Data
por: Aslaner Ak, Müzeyyen, et al.
Publicado: (2023)